Highly purified cannabidiol in the treatment of drug-resistant epilepsies: A real-life impact on seizure frequency, quality of life, behavior, and sleep patterns from a single Italian center
G. Ferrera(AOL (United States)), Maria Paola Canevini(University of Milan), Davide Caputo(Fondazione IRCCS Istituto Neurologico Carlo Besta), Francesca La Briola(University of Milan), Aglaia Vignoli(University of Milan), Miriam Nella Savini(European Hospital), Emilia Ricci(University of Milan), Ilaria Viganò(Ospedale Valduce), Elena Zambrelli(Ospedale San Paolo), Valentina Chiesa(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Katherine Turner(Ospedale San Paolo)
Cited by 8
Related Papers
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry
|The Lancet Neurology|2018|537
COVID-19 pandemic: health impact of staying at home, social distancing and ‘lockdown’ measures—a systematic review of systematic reviews
|Journal of Public Health|2021|202
Supporting access to healthcare for refugees and migrants in European countries under particular migratory pressure
|BMC Health Services Research|2019|165